pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,705 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT967Endpoints742BioPharma Dive283BioSpace181Fierce Biotech172onclive165globenewswire health73raps
therapy area
allOncology5621Rare Disease1252Cardiology1054Hematology939Immunology932Vaccines816Pulmonology
  • Opinion: How long Covid’s scientific stalemate made it politically erasable
    Long Covid hasn’t disappeared. It’s just gone underground, writes Steven Phillips.
    STAT · 2mo ago↗ source
  • STAT+: Scientists see promise in NIH proposal to cap number of grants they receive
    Without easy access to leaders within a field or top-of-the-line lab equipment, principal investigators outside top universities often struggle to compete for grants from the NIH.
    STAT · 2mo ago↗ source
  • STAT+: Private Medicare plans erect barriers to rehab care in pursuit of profit, federal investigators find
    Federal investigation finds Medicare Advantage insurers block rehab care for older adults, only to reverse denials on appeal.
    STAT · 2mo ago↗ source
← prev
page 47 of 69
next →
65
fda recalls37
fda medwatch36
fda press25
782
Psychiatry & CNS690
Ophthalmology345
Pain342
Endocrinology & Metabolism340
Infectious Disease331
  • Diabetes association leader apologizes for expulsion of members, pledges to rebuild trust
    The American Diabetes Association CEO apologizes to five members kicked out of annual convention for distributing protest literature, launches review of what went awry.
    STAT · 2mo ago↗ source
  • STAT+: Your sepsis algorithm shouldn’t require a time machine
    In this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.
    STAT · 2mo ago↗ source
  • Ethyreal starts up with $101M and takes aim at a pair of immune diseases
    The startup is developing a medicine that works differently than available treatments for thyroid eye disease and could benefit people with a related condition, too.
    BioPharma Dive · 2mo ago↗ source
  • Sanofi stops immune drug trial in latest research setback
    The failure adds to a series of mixed or negative readouts and leaves in doubt the future of a therapy Sanofi has viewed as a potential blockbuster.
    BioPharma Dive · 2mo ago↗ source
  • Parabilis sets a record with a $670M biotech IPO
    The largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now resulted in 12 drug startups securing more than $4.1 billion combined.
    BioPharma Dive · 2mo ago↗ source
  • OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendations
    The American College of Obstetricians and Gynecologists has released a recommended vaccine schedule during pregnancy, one that diverges from CDC guidance.
    STAT · 2mo ago↗ source
  • STAT+: Hope for Kendall Square’s lab market
    Drug pricing in Europe, AI deals for VC firms, and more biotech news from The Readout
    STAT · 2mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more
    A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024
    STAT · 2mo ago↗ source
  • AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
    Newly published data convinced AstraZeneca to conduct a sprawling late-stage program for its GLP-1 pill. Elsewhere, Bausch + Lomb will lay off 119 employees and Cartesian boosted its ‘in vivo’ cell…
    BioPharma Dive · 2mo ago↗ source
  • DOJ reaches second settlement on youth gender care
    A new era of American sunscreen, NIAID taps new acting director, and more health news from Morning Rounds
    STAT · 2mo ago↗ source
  • Are Republicans turning against medications for treating opioid addiction?
    Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.
    STAT · 2mo ago↗ source
  • STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
    In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.
    STAT · 2mo ago↗ source
  • Opinion: Even in abortion-protecting states, teens face unnecessary barriers to care
    “Legal protection for abortion does not mean equitable access for minors,” a pediatrics resident writes.
    STAT · 2mo ago↗ source
  • Opinion: ‘They all think I’m insane’: What it’s like to start medical residency at 72
    “I know what I’m getting into”: Dawn Zuidgeest-Craft on starting medical residency at almost 73.
    STAT · 2mo ago↗ source
  • STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds
    The number of prescription drug shortages in the U.S. fell by 23% last year, but a new analysis found other troubling signs about medicines in short supply.
    STAT · 2mo ago↗ source
  • STAT+: Trump’s health care affordability czar takes aim at hospitals
    Plus a buried alcohol study gets published, and a Biosecure update.
    STAT · 2mo ago↗ source
  • Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
    The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an editorial criticizing federal research cuts.
    STAT · 2mo ago↗ source
  • FDA OKs first new sunscreen ingredient in more than 25 years
    Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years.
    STAT · 2mo ago↗ source
  • Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
    Trodelvy's latest setback carries implications for a newly important Merck drug, while the success of a once-weekly HIV tablet could boost Gilead's main business.
    BioPharma Dive · 2mo ago↗ source
  • Stealthy startup Treeline plans a reverse merger
    Led by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more following closely behind.
    BioPharma Dive · 2mo ago↗ source
  • Trump administration warns more than 500 hospitals to provide more price information or face fines
    The Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information.
    STAT · 2mo ago↗ source
  • Gilead and Merck’s latest trial success and flop
    AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout
    STAT · 2mo ago↗ source